Site Map
- Home Page
- Connect With Our Medical Team
- Congresses & Publications
- Medical Inquiries
- Other Resources
- About Us
Please confirm below to continue:
I confirm that I am a healthcare professional (HCP) practicing in the United States, or acting on behalf of an HCP.
or
I am a formulary decision maker (FDM) and/or working on behalf of a public or private payer organization to review scientific information to make drug selection or acquisition, formulary management, or coverage and reimbursement decisions on a population basis in the United States.
The contents of this site are not intended for individuals who are not HCPs or FDMs, or for any individual outside of the United States. The dissemination of this information may be subject to different medical and regulatory requirements in other countries.
Links to other websites are provided for your convenience and general informational purposes only. The terms of use and privacy statement on this Indivior US Medical Affairs website will not apply to other websites. Indivior does not endorse websites that are not owned or operated by Indivior. Indivior recommends you carefully review the terms of use and privacy statement of any other websites, and reminds you that you are solely responsible for your interactions on any other websites. By clicking "Continue to External Website" you will exit the Indivior US Medical Affairs website.
Clicking the Continue button below will direct you to the Buprenorphine-containing Transmucosal products for Opioid Dependence (BTOD) Risk Evaluation and Mitigation Strategies (REMS) Program website, BTODREMS.com.
Indivior Inc. does not own, manage, or operate the BTOD REMS Program website, and you are solely responsible for any and all interactions with BTODREMS.com; accordingly, please review the BTOD REMS Program website's privacy policy and terms of use.